DIRS.INFO The most relevant business & tech news

☆ Updated Covid-19 vaccines are coming mid-September, officials say
▼ + stars: | 2023-08-25 | by ( Brenda Goodman | ) edition.cnn.com time to read: +5 min

CNN —Covid-19 vaccines that have been tweaked to teach the body how to fend off the current crop of circulating variants are now expected to land in drugstores and clinics in mid-September, senior administration officials say. The US Food and Drug Administration is expected to give its nod to the updated vaccines in a few weeks. Officials said ACIP will meet quickly after the FDA decision in order to expedite the regulatory steps and get the vaccines to market. The advisory group is scheduled to meet to discuss Covid-19 vaccines on September 12, meaning the vaccines could become available soon after. The details of the pharmacy program are still being worked out, and there may be a slight lag in getting free vaccines at some stores.

Persons: CNN —, ACIP, Mandy Cohen, ”, Dr, Sanjay Gupta, Cohen, There’s Organizations: CNN, US Food and Drug Administration, US Centers for Disease Control, Officials, CDC, Covid, Pfizer, Moderna, FDA, EG, Affordable, CVS, Walgreens, Walmart, CNN Health Locations: drugstores, Covid

☆ It may be time to break out the masks against Covid, some experts say
▼ + stars: | 2023-08-23 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +9 min

“And since the masks that are most effective are N95 that are now readily available, that’s the kind of mask you should wear,” he added. But the agency doesn’t make a broad recommendation for everyone to adopt masks. Morris Brown College in Atlanta announced a return to mandated physical distancing and masks just one week after classes started in August. And pediatricians are poised for the typical return-to-school surge in all kinds of respiratory illness, whether colds, flu or Covid. “The virus is always lurking, waiting for openings, so I think Covid is just going to be a bit of a roller coaster, probably forever,” Wachter said.

Persons: Joe Biden, Jonathan Reiner, “, ” Reiner, Biden, ”, Reiner, Eric Topol, ” Topol, ” What’s, Robert Wachter, ” Wachter, haven’t, Peter Chin, Topol, Dr, Sara Bode, Bode, It’s, ‘, ” Chin, Hong, You’ve, you’ve, Amanda Musa, Brenda Goodman, Deidre McPhillips, Meg Tirrell Organizations: CNN, George Washington University School of Medicine & Health Sciences, US Centers for Disease Control, CDC, Scripps, Research, Covid, Department of Medicine, University of California San, University of California, Morris Brown College, Nationwide Children’s Hospital, American Academy of Pediatrics ’, School Health, Internal Locations: Covid, Florida, University of California San Francisco, San Francisco, Atlanta, Columbus , Ohio, Washington

☆ US CDC says new COVID lineage could cause infections in vaccinated individuals
▼ + stars: | 2023-08-23 | by ( ) www.reuters.com time to read: +1 min

CDC said it was too soon to know whether this might cause more severe illness compared with previous variants. But due to the high number of mutations detected in this lineage, there were concerns about its impact on immunity from vaccines and previous infections, the agency said. Scientists are keeping an eye on the BA.2.86 lineage because it has 36 mutations that distinguish it from the currently-dominant XBB.1.5 variant. The agency had earlier this month said it was tracking the highly mutated BA.2.86 lineage, which has been detected in the United States, Denmark and Israel. CDC said on Wednesday the current increase in hospitalizations in the United States is not likely driven by the BA.2.86 lineage.

Persons: Pratik Jain, Shilpi Majumdar Organizations: Science, Trinity College, Reuters, U.S . Centers for Disease Control, Prevention, CDC, Thomson Locations: Dublin, Wuhan, United States, Denmark, Israel, hospitalizations, Bengaluru

☆ Novavax shares surge after drugmaker says new Covid vaccine was effective against Eris variant
▼ + stars: | 2023-08-22 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Shares of Novavax jumped more than 13% on Tuesday after the biotech company said its new Covid vaccine generated a broad immune response against the now-dominant Eris variant and another fast-spreading strain of the virus in small animal trials. But the trial results suggest that the shot may still be effective against newer Covid variants gaining a greater foothold in the U.S. That includes Eris and XBB.1.16.6, both of which are also descendants of omicron. "We have a lot of confidence in our updated Covid vaccine and are working diligently with global regulatory bodies to ensure our protein-based vaccine is available this fall," Filip Dubovsky, Novavax's president of research and development, said in a release. The World Health Organization designated Eris a "variant of interest," meaning it will be monitored for mutations that could make it more severe. XBB.1.16.6 is also beginning to surge, accounting for 8% of all cases nationwide as of Saturday, the CDC said.

Persons: Novavax, Filip Dubovsky Organizations: Pfizer, Moderna, U.S . Food, Drug Administration, EG, Centers for Disease Control, World Health Organization, CDC Locations: U.S, hospitalizations

☆ Tacoma Listeria outbreak: Three dead after drinking Frugals restaurant milkshakes
▼ + stars: | 2023-08-20 | by ( Sara Smart | ) edition.cnn.com time to read: +2 min

CNN —Three people have died and three others have been hospitalized after drinking milkshakes contaminated with Listeria bacteria from a restaurant in Tacoma, Washington, health officials say. Investigators found the outbreak was linked to ice cream machines that were not cleaned properly at a Frugals restaurant in Tacoma, according to a release from the Washington State Department of Health. Two of the three who survived said they had a milkshake from the same Frugals in Tacoma before getting sick. The health department said no other Frugals restaurants are believed to be affected by the outbreak. Anyone who ate at the Tacoma restaurant between May 29 and August 7 and is showing symptoms of Listeria is urged to contact a doctor, the agency cautioned.

Organizations: CNN, Washington State Department of Health, Tacoma, Centers for Disease Control Locations: Tacoma , Washington, Tacoma, United States

☆ What I learned about getting older: The scarlet letter ‘A’ is for aging
▼ + stars: | 2023-08-20 | by ( Dr. Sanjay Gupta | ) edition.cnn.com time to read: +14 min

But I don’t think we’re all aware of the age beliefs. To do that, researchers like him are targeting the essential biology of aging – the underlying reasons why we get old. When those biological processes fail or break down, we get sick – and aging is the biggest risk factor for that deterioration. In the meantime, though, remember this: Aging is probably not nearly as bad as you might imagine. And as my mom told me, we should all truly embrace getting older, because it sure as heck beats the alternative.

Persons: ”, “, Diana Nyad, ‘, Diana, I’m, Don’t, she’s, Dan Buettner, Dan, –, Becca Levy, Levy, It’s, Ellsworth, Wareham, Nir Barzilai, Barzilai, ” Barzilai, ’ ”, Dr, Sanjay Gupta, CNN’s Andrea Kane Organizations: CNN, Yale, Albert Einstein College of Medicine, Einstein Institute for Aging Research, FDA, CNN Health Locations: Cuba, Florida, United States, Japan, Ellsworth Wareham, Loma Linda , California

Scientists are keeping an eye on the new lineage, named BA.2.86, because it has 36 mutations that distinguish it from the currently-dominant XBB.1.5 variant. So far there is no evidence that BA.2.86 spreads faster or causes more serious illness than previous versions. COVID infections and hospitalizations have been rising in the U.S., Europe and Asia, with more cases in recent months attributed to the EG.5 "Eris" subvariant, a descendant of the Omicron lineage that originally emerged in November 2021. But many countries have drastically reduced testing of patients and their efforts to analyze the genomes of the viruses causing new COVID cases. Updated COVID booster shots now being developed have been designed to target the Omicron subvariant XBB.1.5.

Persons: Emily Elconin, Wesley Long, Eric Topol, Topol, Long, Moderna, Eris, Deena Beasley, Nancy Lapid, David Gregorio Our Organizations: REUTERS, Moderna Inc, Pfizer, World Health Organization, U.S . Centers for Disease Control, CDC, EG, Omicron, Houston Methodist Hospital, Scripps Research, COVID, U.S, Pfizer Inc, Thomson Locations: Waterford , Michigan, U.S, Europe, Asia, United States, Israel, Denmark, La Jolla , California

☆ New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant
▼ + stars: | 2023-08-18 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

New Covid vaccines from Pfizer , Moderna and Novavax will likely provide protection against the new "Eris" variant, now the dominant strain of the virus in the U.S. The drugmakers designed their updated vaccines to target the omicron subvariant XBB.1.5, which is slowly declining nationwide. Eris accounted for 17.3% of all cases in the U.S. as of earlier this month, according to the latest data from the CDC. The World Health Organization earlier this month designated Eris a "variant of interest," meaning it will be monitored for mutations that could potentially make it more severe. It's also not expected to cause a huge wave of Covid cases like other strains have in previous years.

Persons: Dr, Mark Mulligan, It's Organizations: Chicago Department of Public Health, Southwest Senior Center, Pfizer, Moderna, U.S, EG, NYU, Vaccine, CNBC, Food and Drug Administration, Disease Control, CDC, World Health Organization Locations: Covid, Chicago , Illinois, Novavax, U.S

☆ Moderna says new Covid vaccine was effective against Eris variant in early trial
▼ + stars: | 2023-08-17 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Moderna's new Covid vaccine generated a robust immune response against the now-dominant Eris variant and another rapidly spreading strain of the virus in an early clinical trial, the biotech company said Thursday. The updated shot is designed to target omicron subvariant XBB.1.5, but the results suggest that the jab may still be effective against newer variants of the virus that are gaining ground nationwide. That includes Eris and another variant nicknamed Fornax, both of which are also descendants of the omicron virus variant. The World Health Organization designated Eris a "variant of interest," meaning it will be monitored for mutations that could make it more severe. A Pfizer spokesperson on Thursday said the company's own updated Covid shot effectively neutralized XBB.1.5 and Eris, among other variants, in a recent trial on mice.

Persons: Eris Organizations: omicron, Pfizer, Novavax, U.S . Food, Drug Administration, EG, Centers for Disease Control, World Health Organization, CDC Locations: U.S

☆ Pfizer's updated COVID shot effective against 'Eris' variant in mice study
▼ + stars: | 2023-08-17 | by ( ) www.reuters.com time to read: +1 min

Pfizer, along with its German partner BioNTech SE (22UAy.DE), as well as other COVID-19 vaccine makers Moderna (MRNA.O) and Novavax (NVAX.O) have created versions of their shots, which are aimed at the XBB.1.5 subvariant. EG.5, nicknamed by some as "Eris", is similar to the XBB.1.5 subvariant and a sub-lineage of the still-dominant Omicron variant. EG.5 accounted for about more than 17% of COVID-19 cases in the United States, according to the latest government data. In the United States, COVID-19 related hospitalizations are up more than 40% off of recent lows hit in June, but are still more than 90% below peak levels hit during the January 2022 Omicron outbreak. Reporting by Pratik Jain in Bengaluru; Editing by Shilpi MajumdarOur Standards: The Thomson Reuters Trust Principles.

Persons: Chris Aluka Berry, BioNTech, Pratik Jain, Shilpi Majumdar Organizations: Dekalb Pediatric Center, REUTERS, Pfizer, Pfizer Inc, Moderna, EG, World Health Organization, Thomson Locations: Dekalb, Georgia, Decatur , Georgia, U.S, United States, China, South Korea, Japan, Canada, Bengaluru

☆ Moderna's updated COVID vaccine effective against 'Eris' variant in humans
▼ + stars: | 2023-08-17 | by ( ) www.reuters.com time to read: +2 min

Vials of the Moderna COVID-19 vaccine are seen at Apotex pharmaceutical company as Humber River Hospital's mobile vaccine clinic vaccinate employees as part of the coronavirus disease (COVID-19) vaccination campaign, in Toronto, Ontario, Canada April 13, 2021. REUTERS/Carlos Osorio/File Photo Acquire Licensing RightsCompanies BioNTech SE FollowModerna Inc FollowNovavax Inc Follow Show more companiesAug 17 (Reuters) - Moderna (MRNA.O) said on Thursday an initial study data showed its updated COVID-19 vaccine to be effective against the "Eris" and "Fornax" subvariants in humans. Moderna and other COVID-19 vaccine makers Novavax (NVAX.O), Pfizer (PFE.N) and German partner BioNTech SE (22UAy.DE) have created versions of their shots aimed at the XBB.1.5 subvariant. Earlier on Thursday, Pfizer reported that its updated COVID-19 shot, co-developed with BioNTech, showed neutralizing activity against the Eris subvariant in a study conducted on mice. Eris, the nickname for EG.5, is similar to the XBB.1.5 subvariant and a sub-lineage of the still-dominant Omicron variant.

Persons: Carlos Osorio, BioNTech, Pratik Jain, Shilpi Majumdar Organizations: Moderna, REUTERS, Pfizer, EG, Omicron, World Health Organization, Thomson Locations: Humber, Toronto , Ontario, Canada, United States, Europe, U.S, Bengaluru

☆ Covid Eris: What to know about new variant EG.5 dominating U.S. cases
▼ + stars: | 2023-08-14 | by ( Michael Erman | ) www.reuters.com time to read: +2 min

NEW YORK, Aug 14 (Reuters) - COVID infections and hospitalizations are on the rise in the U.S., Europe and Asia. Health officials are pointing at the EG.5 "Eris" coronavirus, a subvariant of the Omicron lineage that originally emerged November of 2021. EG.5 had been found in more than 50 countries as of August 8, according to the WHO. It is the most common and fastest growing COVID-19 subvariant in the U.S., estimated to be responsible for around 17% of current COVID cases, according to the CDC. EG.5 is similar to XBB.1.5 although the newer subvariant carries one mutation to its spike protein, the part of the virus targeted by the vaccine.

Persons: Mandy Cohen, Cohen, Michael Erman, Caroline Humer, Diane Craft Organizations: Health, EG, Omicron, World Health Organization, WHO, CDC, Pfizer, Thomson Locations: U.S, Europe, Asia

☆ How to Think About Rising Covid Cases in California
▼ + stars: | 2023-08-14 | by ( Soumya Karlamangla | More About Soumya Karlamangla | ) www.nytimes.com time to read: +1 min

It’s been several months since I last wrote about it in this newsletter, and almost as long since I gave it serious consideration. The rate of spread has been relatively low this year, and Covid hospitalizations in California were lower last month than at any time since the pandemic took hold. New Covid cases have been rising this month in California and across the country. While experts say the trend isn’t a cause for alarm, they do agree it’s something to monitor if you’re hoping to avoid infection. “I’m sure many of you are anecdotally both hearing about friends and family and colleagues, as well as seeing more or hearing more about some more circulating Covid.”

Persons: It’s, Covid, Erica Pan, “, ” Locations: California

☆ New Covid vaccines are on the way as 'Eris' variant rises
▼ + stars: | 2023-08-14 | by ( Michael Erman | ) www.reuters.com time to read: +5 min

Some public health experts hope that Americans will welcome the new shot as they would a flu jab. In the fall of 2022, by which time most people had either had the COVID virus or the vaccine, fewer than 50 million people got the shots. Its biggest rival, Moderna, conceded demand could be as few as 50 million shots. POST PANDEMIC VACCINEThe COVID public health emergency ended in May and the government has handed much of the duty of vaccinating America to the private sector. As with the flu, Pfizer (PFE.N)/BioNTech SE (22UAy.DE), Moderna (MRNA.O) and Novavax (NVAX.O), have created versions of the COVID vaccine to try to match the variant they believe will be circulating this fall.

Persons: Dado Ruvic, Ashley Kirzinger, Kirzinger, BioNTech, Jefferies, Michael Yee, " Yee, Mandy Cohen, William Schaffner, Schaffner, David Boulware, Michael Erman, Caroline Humer, Diane Craft Organizations: REUTERS, CVS Health, Family, Reuters, Pfizer –, Moderna, Pfizer, U.S . Centers for Disease Control, Prevention, CDC, U.S . Food, Drug Administration, EG, Vanderbilt University, University of Minnesota, Thomson Locations: U.S, America, United States, COVID, CDC's

The World Health Organisation (WHO) logo is seen near its headquarters in Geneva, Switzerland, February 2, 2023. "Collectively, available evidence does not suggest that EG.5 has additional public health risks relative to the other currently circulating Omicron descendent lineages," the WHO said in a risk evaluation. COVID-19 has killed more than 6.9 million people globally, with more than 768 million confirmed cases since the virus emerged. Maria Van Kerkhove, the WHO's technical lead on COVID-19, said EG.5 had an increased transmissibility but was not more severe than other Omicron variants. Director General Tedros Adhanom Ghebreyesus deplored that many countries were not reporting COVID-19 data to WHO.

Persons: Denis Balibouse, Maria Van Kerkhove, Tedros Adhanom Ghebreyesus, Van Kerkhove, Leroy Leo, Gabrielle Tétrault, Farber, Toby Chopra, Angus MacSwan Organizations: World Health Organisation, REUTERS, World Health Organization, EG, WHO, Thomson Locations: Geneva, Switzerland, United States, China, South Korea, Japan, Canada, Bengaluru

☆ New Covid variant: EG.5 is on the rise as coronavirus cases and hospitalizations go up
▼ + stars: | 2023-08-09 | by ( Brenda Goodman | ) edition.cnn.com time to read: +6 min

CNN —There’s a new coronavirus variant topping the leaderboard in the United States: EG.5. And it represents another incremental tweak to the virus rather than a major evolutionary leap like the original Omicron strain. This mutation has appeared in other coronavirus variants before. EG.5 also now has its own offshoot, EG.5.1, that adds a second mutation to the spike. Topol says the US can’t afford to delay its Covid-19 vaccine rollout.

Persons: CNN —, it’s, David Ho, ” Ho, ”, Eric Topol, Anne Hahn, Dan Barouch, virologist, ” Topol, Mandy Cohen, Topol, Dr, Sanjay Gupta Organizations: CNN, EG, US Centers for Disease Control, Columbia University, Scripps, Research, World Health Organization, Yale School of Public Health, Harvard University, US Food and Drug Administration, CDC, CNN Health, FDA Locations: United States, Northeast, FL, Ireland, France, Japan, China, Boston

☆ Gilead quarterly profit falls on COVID sales drop, legal settlement charge
▼ + stars: | 2023-08-03 | by ( ) www.reuters.com time to read: +2 min

[1/2] Gilead Sciences is seen during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File PhotoCompanies Gilead Sciences Inc FollowAug 3 (Reuters) - Gilead Sciences (GILD.O) on Thursday reported lower second-quarter profit as costs from a legal settlement and sharply lower sales of its COVID-19 treatment offset another strong performance by HIV drugs. The drugmaker raised its full-year revenue forecast, even as it trimmed its estimate for COVID antiviral Veklury due to lower pandemic-related hospitalizations. Wall Street analysts had expected an adjusted profit of $1.64 per share on revenue of $6.44 billion, according to Refinitiv data. The California-based company raised the low end of its 2023 revenue forecast range to $26.3 billion from $26.0 billion, but kept the high end at $26.7 billion.

Persons: Mike Blake, Gilead, Deena Beasley, Michael Erman, Bill Berkrot Organizations: Gilead Sciences, REUTERS, Wall Street, Thomson Locations: Oceanside , California, U.S, Gilead, California

☆ Amid Signs of a Covid Uptick, Researchers Brace for the ‘New Normal’
▼ + stars: | 2023-08-02 | by ( Apoorva Mandavilli | More About Apoorva Mandavilli | ) www.nytimes.com time to read: +1 min

Echoing patterns in prior years, coronavirus infections are slowly ticking up in parts of the country, the harbinger of a possible fall and winter wave. But the numbers remain low for now, and are unlikely to reach the horrific highs seen in previous winters, experts said in interviews. Wastewater analyses point to the highest increases in the Northeast and the South, followed by the West and Midwest. After hitting a trough at the end of June, hospitalizations are inching upward again, but fortunately very slowly. Test positivity has risen to 7.6 percent, a level last seen in November 2021, and that summer, just before the Delta variant swept the nation.

Persons: hospitalizations Organizations: West Locations: Northeast, Midwest

☆ Summer Covid surge? Cases and hospitalizations rise
▼ + stars: | 2023-08-01 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSummer Covid surge? Cases and hospitalizations riseDr. John Torres, NBC News contributor, joins 'Power Lunch' to discuss pharmaceutical earnings and the surge in Covid-19 cases.

Persons: John Torres Organizations: NBC

☆ Texans are staying inside during record heat — and the state's economy could take a $9.5 billion hit from reduced business
▼ + stars: | 2023-07-29 | by ( Eliza Relman | Noah Sheidlower | ) www.businessinsider.com time to read: +5 min

In Texas, that could mean a $9.5 billion hit to the state's GDP if the extreme heat continues. As extreme heat grips much of the US this summer and the Earth records its hottest month on record, people are staying inside. Pardue told Insider he was surprised at the magnitude of the decline in hours worked as a result of extreme heat. "And then we're seeing, long term, this opposite shift, where during the summer, there's all this extreme heat." Are you staying home or working fewer hours because of extreme heat?

Persons: —, Luke Pardue, Pardue, we've, Ray Perryman, Jonathan Horowitz, Andreas Flouris Organizations: Service, Workers, Wall Street, Buffalo Bayou Brewing, Nationwide, The National Energy Assistance, Association, Research, University of Thessaly, New York Times, Nature Conservancy, Phoenix, Louisiana Department of Health, erelman Locations: Texas, Houston, Greece, Arizona, New Orleans

☆ New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
▼ + stars: | 2023-07-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +7 min

Regardless of that shift, experts say vaccine uptake may not look much different from that of the bivalent boosters. Pandemic fatigue, confusionFatigue over the pandemic and the general belief that Covid is "over" could potentially hinder the uptake of new shots this fall, experts said. Ipsos and Axios released a survey with similar findings in May, the same month the U.S. ended the national Covid public health emergency amid a downward trend in cases, hospitalizations and deaths. "That contrasts with what we've seen in the past where there are different vaccines, different timing, different age groups and something new to consider every few months." Advisors to the FDA have raised concerns about shifting to yearly Covid vaccines, noting that it's unclear if the virus is seasonal like the flu.

Persons: Antonio Perez, Axios, isn't, Dr, Kartik Cherabuddi, Brad Pollock, Pollock, they're, Ashley McGee, Justin Sullivan, CDC hasn't, Covid, KFF's Kates, Michael Nagle, Kates, we've Organizations: Chicago CVS, Tribune, Service, Getty Images Pfizer, Moderna, Pfizer, Gallup, University of Florida, CNBC, UC Davis Health's, Safeway, CDC, Food and Drug Administration, Health, Human Services Department, FDA, Xinhua News Agency, Getty Locations: Chicago, U.S, San Rafael , California, New York, United States

☆ Mysterious meat allergy passed by ticks may affect hundreds of thousands in US, CDC estimates
▼ + stars: | 2023-07-27 | by ( Brenda Goodman | ) edition.cnn.com time to read: +9 min

Lack of awareness, lack of diagnosisScientists have only recently begun to understand alpha-gal syndrome. Another third of respondents said they were not confident about their ability to diagnose or manage a patient with alpha-gal allergy. Diagnoses on the riseResearchers haven’t had a good idea how many Americans might have alpha-gal syndrome. This led to them to estimate that between 96,000 and 450,000 Americans may have been affected by alpha-gal syndrome since 2010. A CDC map shows the geographic distribution of suspected alpha-gal syndrome cases per 1 million population per year from 2017 to 2022.

Persons: Ken McCullick, “, …, “ I’m, ” McCullick, ”, Scott Commins, aren’t, they’d, wasn’t, haven’t, epidemiologists, Commins, ” Commins, Johanna Salzer, CNN Salzer, ” Salzer, Salzer, McCullick, Dr, Sanjay Gupta, anaphylaxis, ‘, ’, lightbulb Organizations: CNN, Alpha, US Centers for Disease Control, University of North Carolina School of Medicine, CDC, “, Get CNN, CNN Health Locations: Brooksville , Florida, United States, Lenexa , Kansas, Midwest

☆ What’s ahead this week for Wall Street and the economy
▼ + stars: | 2023-07-23 | by ( Krystal Hur | ) edition.cnn.com time to read: +5 min

Case Shiller house price index for May and consumer confidence for July from the Conference Board. Earnings reports from AT&T, Boeing, Meta Platforms, Mattel, Stellantis and Chipotle Mexican Grill. Earnings reports from Coca-Cola, Mondelez, Honeywell, Keurig Dr Pepper, Royal Caribbean, Anheuser-Busch Inbev, Southwest Airlines and Hershey. Friday: Personal Consumption Expenditures price index for June, Employment Cost Index for the second quarter and University of Michigan consumer sentiment for July. Earnings reports from Procter & Gamble, Chevron and Exxon Mobil.

Persons: Jerome Powell, David Smith, Powell, Christopher Waller, ”, Dustin Thackeray, Tesla, Chris Isidore, —, Case, Dr Pepper Organizations: CNN Business, Bell, CNN, Fed, Traders, Rockland Trust, Big Tech, Microsoft, Meta, Crewe Advisors, Nasdaq, Netflix, Safety, Health Administration, doesn’t, Biden Administration, Bureau of Labor Statistics —, Ryanair, Federal Reserve, Conference Board, General Motors, Daniels, Midland, Verizon, PacWest, Boeing, Mattel, Honeywell, Anheuser, Busch Inbev, Southwest Airlines, Hershey, University of Michigan, Procter & Gamble, Chevron, Exxon Mobil Locations: Rockland, American, United States, PacWest Bank, Royal Caribbean

It was Dr. Scott Rivkees, the Florida surgeon general. Ron DeSantis had decided that the worst was over for Florida, he said. Mr. DeSantis had begun listening to doctors who believed the virus’s threat was overstated, and he no longer supported preventive measures like limiting indoor dining. Mr. DeSantis was going his own way on Covid. Nearly three years later, the governor now presents his Covid strategy not only as his biggest accomplishment, but as the foundation for his presidential campaign.

Persons: Deborah L, Scott Rivkees, “, ’ ”, Ron DeSantis, DeSantis, ” Organizations: White, Gov, The New York Times Locations: Florida, Covid, New York, California

☆ US FDA approves Sanofi-AstraZeneca's preventive RSV therapy for babies
▼ + stars: | 2023-07-17 | by ( ) www.reuters.com time to read: +2 min

July 17 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi (SASY.PA) and partner AstraZeneca's (AZN.L) antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers. The therapy, branded Beyfortus, was approved for preventing lower respiratory tract disease in infants born during or entering their first RSV season, and in children up to 24 months of age who remain vulnerable to severe RSV disease through their second such season. The companies plan to make Beyfortus available in the United States ahead of the upcoming RSV season, Sanofi said, adding that it plans to share more information about the therapy's price closer to the season. RSV is a leading cause of hospitalizations in infants and so far Swedish Orphan Biovitrum's (SOBIV.ST) treatment, Synagis, was the only approved preventive therapy in the United States for high-risk infants. The therapy comes with warnings and precautions about serious hypersensitivity reactions, and should be given with caution to infants and children with clinically significant bleeding disorders, the FDA said.

Persons: AstraZeneca's, Sanofi, Beyfortus, Bhanvi Satija, Shinjini Ganguli, Maju Samuel Organizations: U.S . Food, Drug Administration, Sanofi, American Academy of Pediatrics, FDA, Thomson Locations: U.S, United States, Bengaluru

Search resuls for: "Hospitalizations"

25 mentions found